COMMUNIQUÉS West-GlobeNewswire

Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference
11/09/2025
EAGLE, Idaho, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Global Pioneer: KFSHRC Showcases Robotic Organ Transplantation Leadership at C3 Davos of Healthcare™ New York Summit
11/09/2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has reinforced its position as a global pioneer in organ transplantation, marked by the world’s first fully [...]
Aesthetic Room Opens New Aesthetic Medicine Center in South Tyrol (Alto Adige) Near Merano and Bolzano
11/09/2025
Algund/Lagundo, South Tyrol (Alto Adige), Italy , Sept. 11, 2025 (GLOBE NEWSWIRE) -- Aesthetic Room , a new center for modern, minimally invasive aesthetic medicine , has officially opened in Algund , near Merano and [...]
Annual Report 2024/25 - Growing revenue and EBITDA
11/09/2025
ANNOUNCEMENT NO. 292 11 September 2025 Annual Report 2024/25 (1 July 2024 - 30 June 2025) Growing revenue and EBITDA ChemoMetec’s revenue grew by 22% to DKK 495.6 million in 2024/25, and operating profit (EBITDA) [...]
Guidance for the 2025/26 financial year
11/09/2025
ANNOUNCEMENT NO. 291 11 September 2025 Guidance for the 2025/26 financial year ChemoMetec today approved the annual report for 2024/25, including the guidance for 2025/26, which is considered inside information. For [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025
11/09/2025
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2025
11/09/2025
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
11/09/2025
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell [...]
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules
11/09/2025
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites [...]
Ipsen - August 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
11/09/2025
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Août 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
11/09/2025
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Faraday Pharmaceuticals to Participate in Upcoming Investor Events
11/09/2025
Topline data from pivotal Phase 3 Iocyte AMI-3 trial expected in Q4 2025 SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart [...]
RESTEM to Host R&D Day Highlighting its Next-Generation Immunomodulatory Treatment for Autoimmune and Inflammatory Diseases
11/09/2025
Leading KOLs to discuss the unmet needs and current treatment landscapes of idiopathic inflammatory myopathy (IIM), ulcerative colitis (UC), rheumatoid arthritis (RA), and facioscapulohumeral muscular dystrophy (FSHD) [...]
InnovAge Named as One of the Nation’s Best Workplaces in Aging Services™ by Fortune® and Great Place to Work®
11/09/2025
A Leading Provider of PACE, Ranked in Top Tier of 2025 Best in Aging Services Category DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) -- InnovAge (NASDAQ: INNV), a leading provider of Program of All-Inclusive Care for the [...]
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
11/09/2025
Press release – No.13 / 2025 SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 Copenhagen, Denmark, September 11, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a [...]
Acentra Health CEO Todd Stottlemyer Named by Virginia Business to its ‘Virginia 500 Power List’ for Fourth Consecutive Year
11/09/2025
Recognition underscores healthcare leader’s passion for making Virginia an attractive location to live, learn, work, and conduct business MCLEAN, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
11/09/2025
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering
11/09/2025
Grand Cayman, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS- [...]
Mass General Brigham’s Kraft Center Announces Winner and Finalists of the 2025 Kraft Prize for Excellence and Innovation in Community Health
11/09/2025
Boston, MA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Inaugural $100k award goes to St. Louis company making a transformative impact in its community Organizations supporting maternal health and substance use disorder [...]

Pages